Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by made2laston Sep 15, 2017 6:15pm

131 Views

Post# 26703540

RE:RE:RE:Colon Cancer: Easily Reachable

Hi jojomarch;

We understand and agree that we need a lot of $$$ to move forward.

Basically, we are discussing the easy access areas of the body where we can treat the cancer with a PDC intravesically rather than intravenously. That should make it much easier to get an approval for human clinical trials without doing another drug safety trial for each indication.

Thanks;

made2last

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!